Sera Prognostics, Inc.

Sera Prognostics, Inc.

SERAยทNASDAQ

$2.22

+8.3%
HealthcareMedical - Diagnostics & Research

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

At a Glance

Live Snapshot
Market Cap$84.78M
EPS-0.6700
P/E Ratio-3.31
Earnings Date08/05/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

Medium confidence

Valuation multiple is compressed (P/E -3.3).

Valuation inputs: P/E -3.3, earnings yield N/A, momentum +8.3%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is soft (ROE -42.3%, ROIC -46.9%).

Profitability stack: net margin -394.2%, ROE -42.3%, ROIC -46.9%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Risk profile is balanced but has notable pressure points to monitor.

Risk factors: liabilities/assets +26.0%, momentum +8.3%, net margin -394.2%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

sera

Sera Prognostics, Inc. Market vs Earnings Trajectory

SERA ยท NASDAQ

Loading price and EPS data...

Sera Prognostics, Inc.

Sera Prognostics, Inc. Fair Value Envelope

SERA ยท NASDAQ

Our analysis suggests that SERA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.22, this represents a potential HIDDEN relative to our calculated worth for Sera Prognostics, Inc..

Intrinsic Value
Current Price: $2.22
3Y-53.0%
5Y-44.0%
10Y-41.0%
3Y-70.0%
5Y+224.0%
10Y+125.0%
3Y-28.0%
5Y+61.0%
10Y+56.0%
3Y-26.0%
5Y+52.0%
10Y+33.0%
3Y-26.0%
5Y+55.0%
10Y+36.0%
3Y-12.0%
5Y+589.0%
10Y+338.0%
Sera Prognostics, Inc.

Sera Prognostics, Inc. Profit Bridge

SERA ยท NASDAQ
Revenue81.00K
Cost of Goods Sold (164.00K)
Gross Profit-83.00K
Operating Expenses (36.42M)
Operating Income-36.50M
Interest Expense (9.00K)
Other Income/Expense4.58M
Pretax Income-31.93M
Income Tax (0.00)
Net Income-31.93M
Net Income
-31.93M

Profitability Analysis

Gross Margin

-102.5%

Negative gross margin indicates the company is losing money on each saleโ€”unsustainable long-term.

Operating Margin

-45066.7%

Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.

Net Profit Margin

-39417.3%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.

-102.47%
Gross Profit Margin
1478%
3Y-466.0%
5Y-283.0%
10Y-305.0%
-45066.67%
Operating Profit Margin
-5%
3Y+165.0%
5Y-37.0%
10Y-2.0%
-39417.28%
Net Profit Margin
-8%
3Y+139.0%
5Y-50.0%
10Y-31.0%
-42.34%
Return on Equity
-38%
3Y-5.0%
5Y-94.0%
10Y-321.0%
-31.32%
Return on Assets
-31%
3Y-18.0%
5Y-77.0%
10Y-64.0%
-46.95%
Return on Invested Capital
-38%
3Y+5.0%
5Y-70.0%
10Y-52.0%
SERA

Sera Prognostics, Inc. Cash Conversion Engine

SERA ยท NASDAQ
Net Income-31.93M
Depreciation & Amortization940.00K
Stock-Based Compensation5.11M
Change in Working Capital-546.00K
Others801.00K
Capital Expenditures-726.00K
Free Cash Flow-26.35M

Cash Flow Quality Analysis

FCF Conversion Rate

82.5%

Strong cash conversion. Most reported earnings translate into actual cash flow, suggesting solid fundamentals.

CapEx Intensity

-2.8%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

-72.3%

Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.

Working Capital Impact

-$546.00K

Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.

Cash Flow Quality Insight

Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.

sera

Sera Prognostics, Inc. Funding & Solvency Profile

SERA ยท NASDAQ
Cash & Cash Equivalents4.17M
Net Receivables11.00K
Inventory0.00
Other Current Assets2.31M
Total Current Assets50 M
Property, Plant & Equipment1.10M
Goodwill & Intangible Assets881.00K
Long-Term Investments0.00
Other Non-Current Assets41.84M
Total Non-Current Assets43 M
Total Assets
93.54M

Financial Health Analysis

Current Ratio

2.12x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.38x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

26 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

53% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

sera

Sera Prognostics, Inc. Street Expectations Map

SERA ยท NASDAQ

Wall Street analysts project that SERA stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 5.00, with estimates ranging from a low of 5.00 to a high of 5.00.

Lowest Target
5.00
125.23%
Consensus Target
5.00
125.23%
Highest Target
5.00
125.23%

The consensus 1-year price target stands at 5.00, with estimates ranging from a low of 5.00 to a high of 5.00.

Analyst Consensus Analysis

Upside Potential

+125.2%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

0.0% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

Very High

Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.

Market Sentiment Insight

Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.

sera

Sera Prognostics, Inc. Insider Positioning

SERA ยท NASDAQ

During the last 12 months, insiders have purchased $160K and sold $842K worth of SERA shares, resulting in $682K of net selling activity.

3 Months

Bought

0

0.00

Sold

51.1K

99.17K

Net Activity

-99K

-$99K

3-6 Months

Bought

0

0.00

Sold

50.1K

153.11K

Net Activity

-153K

-$153K

6-9 Months

Bought

0

0.00

Sold

129.6K

376.06K

Net Activity

-376K

-$376K

9-12 Months

Bought

100.0K

160.00K

Sold

96.6K

213.65K

Net Activity

-54K

-$54K

Top Buyers

1
KKP

Kamdar Kim P.

Director

25.0K sharesโ€ข1 transactions

$40K

2
CGC

Critchfield Gregory C

Director

25.0K sharesโ€ข1 transactions

$40K

3
PJ

Phillips Joshua

Director

25.0K sharesโ€ข1 transactions

$40K

4
MMR

Mirza Mansoor Raza

Director

25.0K sharesโ€ข1 transactions

$40K

Top Sellers

1
LZ

Lindgardt Zhenya

Director, Officer: Chief Executive Officer

128.9K sharesโ€ข10 transactions

$315K

2
KP

Kearney Paul

Officer: Chief Data Officer

66.9K sharesโ€ข11 transactions

$195K

3
HRG

Harrison Robert Gardner

Officer: Chief Information Officer

38.5K sharesโ€ข15 transactions

$100K

4
AA

Aerts Austin

Officer: Chief Financial Officer

38.9K sharesโ€ข11 transactions

$94K

5
BJJ

Boniface John J.

Officer: Chief Scientific Officer

23.6K sharesโ€ข7 transactions

$58K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $682K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.19:1

Weak buy/sell ratio. Selling significantly exceeds buyingโ€”monitor for potential fundamental concerns.

Recent Trend (3 Months)

$99K

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

Moderate Selling

5 insider sellers vs. 4 buyers. More insiders selling than buying suggests cautious or negative sentiment.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.

No Dividend Yield Data

SERA has not reported any dividend yield values in the available annual periods.

ย 

sera Dividend History

SERA
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%